BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2021
View Archived Issues
Blueprint Medicines to acquire LNG-451 with Lengo Therapeutics acquisition
Read More
Oncostatin M targeting as approach for treating inflammatory pruritus
Read More
Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism
Read More
IBI-319, a novel CD137/PD-1 bispecific antibody with limited systemic toxicity
Read More
Shanghai Longwood Biopharmaceuticals divulges PD-1/PD-L1 interaction inhibitors
Read More
Dartmouth College discloses new GR antagonists
Read More
Txinno Bioscience presents new ENPP1 inhibitors
Read More
Eli Lilly and Company identifies CSF1R inhibitors
Read More
New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D
Read More
B-cell targeting controls chronic viral infections in mice
Read More
New transgenic hACE2-expressing mouse model shows efficacy of vaccine against brain COVID-19
Read More
Discovery of novel antifungal compounds with improved metabolic stability
Read More
PNV-2 reduces metastases in animal model of triple-negative breast cancer
Read More
Scorpion Therapeutics unveils lead programs in cancer
Read More
Polyphenylene carboxymethylene shows anti-SARS-CoV-2 activity in vitro
Read More
Janssen publishes PK/PD data for the anticoagulant-reversing agent JNJ-67842125
Read More
Indomethacin-based PROTACs show pan-coronavirus activity, including SARS-CoV-2 strains
Read More
NHD2 is essential in Leishmania independently of complex I, emerging as a potential drug target
Read More